Patients with multiple myeloma (a blood cancer of plasma cells in the bone marrow) who also have diabetes have a reduced overall survival when compared to those without diabetes. But in a subgroup analysis, this difference in survival due to diabetes was seen in white patients but not in Black patients, according to a study published today in Blood Advances.
Leave A Comment